Indication
Autoimmune Diseases of the Nervous System
4 clinical trials
4 products
1 drug
Clinical trial
Predictors and Prognostic Factors of Myasthenia Gravis OutcomeStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
An Open Label Clinical Trial to Evaluate the Safety and Efficacy of CT103A Cells for the Treatment of Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous SystemStatus: Recruiting, Estimated PCD: 2027-02-22
Product
CT103AClinical trial
Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing Multiple SclerosisStatus: Recruiting, Estimated PCD: 2027-05-01
Drug
VarlilumabClinical trial
Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of Melatonin Administration in Patients With Multiple Progressive Primary SclerosisStatus: Recruiting, Estimated PCD: 2024-07-01
Product
Melatonin